Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 370

1.

Characterization and evaluation of a modified local lymph node assay using ATP content as a non-radio isotopic endpoint.

Idehara K, Yamagishi G, Yamashita K, Ito M.

J Pharmacol Toxicol Methods. 2008 Jul-Aug;58(1):1-10. doi: 10.1016/j.vascn.2008.03.003. Epub 2008 Mar 26.

PMID:
18462956
[PubMed - indexed for MEDLINE]
2.

Interlaboratory validation of the modified murine local lymph node assay based on adenosine triphosphate measurement.

Omori T, Idehara K, Kojima H, Sozu T, Arima K, Goto H, Hanada T, Ikarashi Y, Inoda T, Kanazawa Y, Kosaka T, Maki E, Morimoto T, Shinoda S, Shinoda N, Takeyoshi M, Tanaka M, Uratani M, Usami M, Yamanaka A, Yoneda T, Yoshimura I, Yuasa A.

J Pharmacol Toxicol Methods. 2008 Jul-Aug;58(1):11-26. doi: 10.1016/j.vascn.2008.05.001. Epub 2008 May 21.

PMID:
18593646
[PubMed - indexed for MEDLINE]
3.

Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.

Gerberick GF, Ryan CA, Dearman RJ, Kimber I.

Methods. 2007 Jan;41(1):54-60. Review.

PMID:
16938465
[PubMed - indexed for MEDLINE]
4.

Advantage of using CBA/N strain mice in a non-radioisotopic modification of the local lymph node assay.

Takeyoshi M, Noda S, Yamasaki K, Kimber I.

J Appl Toxicol. 2006 Jan-Feb;26(1):5-9.

PMID:
16217858
[PubMed - indexed for MEDLINE]
5.

A nonradioisotopic endpoint for measurement of lymph node cell proliferation in a murine allergic contact dermatitis model, using bromodeoxyuridine immunohistochemistry.

Lee JK, Park JH, Park SH, Kim HS, Oh HY.

J Pharmacol Toxicol Methods. 2002 Jul-Aug;48(1):53-61.

PMID:
12750042
[PubMed - indexed for MEDLINE]
6.

Assessment of statistic analysis in non-radioisotopic local lymph node assay (non-RI-LLNA) with alpha-hexylcinnamic aldehyde as an example.

Takeyoshi M, Sawaki M, Yamasaki K, Kimber I.

Toxicology. 2003 Sep 30;191(2-3):259-63.

PMID:
12965128
[PubMed - indexed for MEDLINE]
7.

Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.

Takeyoshi M, Iida K, Shiraishi K, Hoshuyama S.

J Appl Toxicol. 2005 Mar-Apr;25(2):129-34.

PMID:
15744759
[PubMed - indexed for MEDLINE]
8.

Inter-laboratory validation of the modified murine local lymph node assay based on 5-bromo-2'-deoxyuridine incorporation.

Kojima H, Takeyoshi M, Sozu T, Awogi T, Arima K, Idehara K, Ikarashi Y, Kanazawa Y, Maki E, Omori T, Yuasa A, Yoshimura I.

J Appl Toxicol. 2011 Jan;31(1):63-74. doi: 10.1002/jat.1567.

PMID:
20677212
[PubMed - indexed for MEDLINE]
9.

ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods.

Haneke KE, Tice RR, Carson BL, Margolin BH, Stokes WS.

Regul Toxicol Pharmacol. 2001 Dec;34(3):274-86.

PMID:
11754531
[PubMed - indexed for MEDLINE]
10.

Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.

Takeyoshi M, Noda S, Yamazaki S, Kakishima H, Yamasaki K, Kimber I.

J Appl Toxicol. 2004 Jan-Feb;24(1):77-81.

PMID:
14745850
[PubMed - indexed for MEDLINE]
11.

ICCVAM evaluation of the murine local lymph node assay. Conclusions and recommendations of an independent scientific peer review panel.

Dean JH, Twerdok LE, Tice RR, Sailstad DM, Hattan DG, Stokes WS.

Regul Toxicol Pharmacol. 2001 Dec;34(3):258-73.

PMID:
11754530
[PubMed - indexed for MEDLINE]
12.

Influence of application vehicle on skin sensitization to methylchloroisothiazolinone/methylisothiazolinone: an analysis using the local lymph node assay.

Warbrick EV, Dearman RJ, Basketter DA, Kimber I.

Contact Dermatitis. 1999 Dec;41(6):325-9.

PMID:
10617213
[PubMed - indexed for MEDLINE]
13.

The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.

Jowsey IR, Clapp CJ, Safford B, Gibbons BT, Basketter DA.

Cutan Ocul Toxicol. 2008;27(2):67-75. doi: 10.1080/15569520801904655.

PMID:
18568891
[PubMed - indexed for MEDLINE]
14.

Use of the local lymph node assay in the evaluation of the sensitizing potential of pharmaceutical process intermediates.

Durand G, de Burlet G, Virat M, Nauman BD.

Contact Dermatitis. 2003 Sep;49(3):148-54.

PMID:
14678211
[PubMed - indexed for MEDLINE]
16.

Development of non-radio isotopic endpoint of murine local lymph node assay based on 5-bromo-2'-deoxyuridine (BrdU) incorporation.

Takeyoshi M, Yamasaki K, Yakabe Y, Takatsuki M, Kimber I.

Toxicol Lett. 2001 Mar 8;119(3):203-8.

PMID:
11246173
[PubMed - indexed for MEDLINE]
17.

Skin sensitization testing in potency and risk assessment.

Kimber I, Basketter DA, Berthold K, Butler M, Garrigue JL, Lea L, Newsome C, Roggeband R, Steiling W, Stropp G, Waterman S, Wiemann C.

Toxicol Sci. 2001 Feb;59(2):198-208. Review.

PMID:
11158712
[PubMed - indexed for MEDLINE]
Free Article
18.

Activity of human contact allergens in the murine local lymph node assay.

Ryan CA, Gerberick GF, Cruse LW, Basketter DA, Lea L, Blaikie L, Dearman RJ, Warbrick EV, Kimber I.

Contact Dermatitis. 2000 Aug;43(2):95-102.

PMID:
10945748
[PubMed - indexed for MEDLINE]
19.

Assessment of the sensitization potential of five metal salts in the murine local lymph node assay.

Mandervelt C, Clottens FL, Demedts M, Nemery B.

Toxicology. 1997 Jun 6;120(1):65-73.

PMID:
9160110
[PubMed - indexed for MEDLINE]
20.

Evaluation of an ex vivo murine local lymph node assay: multiple endpoint comparison.

Piccotti JR, Knight SA, Gillhouse K, Lagattuta MS, Bleavins MR.

J Appl Toxicol. 2006 Jul-Aug;26(4):333-40.

PMID:
16705757
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk